Literature DB >> 20542543

Haemostatic profile of healthy premature small for gestational age neonates.

George Mitsiakos1, Evaggelia Giougi, Ilias Chatziioannidis, Paraskevi Karagianni, Emmanouil Papadakis, Christos Tsakalidis, Georgia Papaioannou, Pavlos Malindretos, Nikolaos Nikolaidis.   

Abstract

BACKGROUND: The pathogenetic profile of premature Small for Gestational Age (SGA) neonates is strongly related to their haemostatic equilibrium, which is inadequately understood.
OBJECTIVE: To evaluate coagulation and fibrinolysis in premature SGA neonates before intervening with Vitamin K administration. STUDY
DESIGN: We performed a comparison of coagulation, natural inhibitors and fibrinolysis between SGA and Appropriate for Gestational Age (AGA) infants born prematurely [gestational age (G.A.) <37 weeks]. Study population consisted of 139 preterm newborns, 68 of whom were SGA (25 males and 43 females), while 71 were AGA (37 males and 34 females) that consisted the control group. Blood samples were obtained within 30 minutes following birth and before the administration of vitamin K. Investigation included: PT, INR, APTT, fibrinogen, coagulation factors II, V, VII, VIII, IX, X, XI, XII, von Willebrand factor, protein C and free protein S, antithrombin (AT), APCR, tPA and PAI-1. The independent t-test and the Mann-Whitney U test were used to compare the differences between the values of haemostatic parameters.
RESULTS: Premature SGA infants presented significantly lower levels of fibrinogen (p<0.029) and higher levels of VIIIc factor, APCR, tPA and PAI-1 (p<0.041, 0.017, 0.021 and 0.019 respectively). The two groups had similar demographic characteristics (except from birth weight), without significant differences in the values of other haemostatic parameters.
CONCLUSIONS: Despite the statistically significant differentiation in the levels of fibrinogen, VIIIc factor, APCR, tPA and PAI-1, the rest of haemostatic parameters have similar values between SGA and AGA preterms. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20542543     DOI: 10.1016/j.thromres.2010.05.010

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Thromboelastometry: studying hemostatic profile in small for gestational age neonates-a pilot observational study.

Authors:  Rozeta Sokou; Aikaterini Konstantinidi; Charikleia Stefanaki; Andreas G Tsantes; Stavroula Parastatidou; Katerina Lampropoulou; George Katsaras; Evagelia Tavoulari; Nicoletta Iacovidou; Elias Kyriakou; Antonios Gounaris; Stefanos Bonovas; Argirios E Tsantes
Journal:  Eur J Pediatr       Date:  2019-02-01       Impact factor: 3.183

Review 2.  Developmental hemostasis in the neonatal period.

Authors:  Vicente Rey Y Formoso; Ricardo Barreto Mota; Henrique Soares
Journal:  World J Pediatr       Date:  2022-01-04       Impact factor: 2.764

3.  Hemostatic profile in healthy premature neonates; does birth weight affect the coagulation profile?

Authors:  Alireza Abdollahi; Sara Sheikhbahaei; Nima Hafezi-Nejad; Behnaz Mahdaviani
Journal:  J Clin Neonatol       Date:  2014-04

Review 4.  The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

Authors:  Juan A De Pablo-Moreno; Luis Javier Serrano; Luis Revuelta; María José Sánchez; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.